TRASIR THERAPEUTICS

Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery. The company has developed an oligonucleotide delivery platform for delivery of short interfering RNA and other therapeutic RNA payloads to sites outside the liver.

#SimilarOrganizations #Website #More

TRASIR THERAPEUTICS

Industry:
Therapeutics

Address:
Tampa, Florida, United States

Country:
United States

Website Url:
http://www.trasirtherapeutics.com

Status:
Active


Similar Organizations

akashi-therapeutics-logo

Akashi Therapeutics

Akashi Therapeutics is a clinical stage biopharmaceutical company.

myx-therapeutics-logo

Myx Therapeutics

MyX Therapeutics is a unique enabling mucosal delivery platform technology company.

recensa-therapeutics-logo

Recensa Therapeutics

Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.

Official Site Inspections

http://www.trasirtherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Trasir Therapeutics"

Trasir Therapeutics - Crunchbase Company Profile & Funding

Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery. The company has developed an oligonucleotide delivery platform for delivery of short interfering RNA and other …See details»

Trasir Therapeutics - PitchBook

Trasir Therapeutics General Information Description. Developer of RNA therapeutics intended to treat diseases with multiple mechanisms of inflammation. The company has programs in …See details»

Trasir Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Trasir Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:TT-960, TT-468.See details»

Tranquis

Aug 29, 2022 Reprogramming immune cells restoring lives Resetting the energy metabolism of dysfunctional immune cells to conquer disease A breakthrough approach for a broad range of …See details»

Home - ShapeTX

We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape TX combines …See details»

Auris Medical Announces Acquisition of RNA Therapeutics

Jun 3, 2021 Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to...See details»

Altamira Therapeutics acquires Trasir Therapeutics - 2021-06-03 ...

Jun 3, 2021 Acquired Organization: Trasir Therapeutics Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery. Acquiring Organization: Altamira Therapeutics Altamira …See details»

Sask. vaccine developer locks in Canadian manufacturers for …

Jul 29, 2020 The University of Saskatchewan has contracted two Canadian pharmaceutical companies to manufacture ingredients for its COVID-19 vaccine for the first stages of human …See details»

Home | Altay Tx

Developing life-saving therapies by targeting disease-causing transcription factors. Our Pipeline. Our TechnologySee details»

Travere Therapeutics: Culture | LinkedIn

Travere Therapeutics | 27,945 followers on LinkedIn. In rare for life. | Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife ...See details»

Flare - Flare Therapeutics | Flare Therapeutics

The Flare Therapeutics team is a living, growing, thriving organization of talented people and bright minds. We are always looking for new sparks to flame our collective fire. Learn more …See details»

McMaster start-up developing new cancer treatments

Nov 16, 2022 Republish this Article We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No Derivs 2.5 Canada (CC BY-ND 2.5 CA), so …See details»

First meeting of the International Health Regulations (2005) …

Aug 19, 2024 The Director-General of the World Health Organization (WHO), having concurred with the advice offered by the International Health Regulations (2005) (IHR or Regulations) …See details»

WHO prequalifies first biosimilar medicine to increase worldwide …

Dec 18, 2019 Today the World Health Organization (WHO) prequalified its first biosimilar medicine – trastuzumab – in a move that could make this expensive, life-saving treatment …See details»

Asha Therapeutics | Reshaping Healthcare

Asha's mission is to make neurological disease a memory.Millions of people globally suffer from debilitating, incurable, and often fatal neurodegenerative and neuromuscular disorders, with …See details»

Compass Therapeutics

We are developing next generation antibodies into transformative cancer therapies that improve patients’ lives. We’re leveraging our understanding of the tumor microenvironment to develop …See details»

Respira Therapeutics

Respira has received reports of employment scams that purport to extend job offers or seek financial commitments from job candidates. Unsuspecting job seekers have reported receiving …See details»

Halia - Revolutionizing Chronic Inflammation Therapy

Inflammation is an essential biological response of the human immune system that protects against disease. However, when dysregulated, inflammation can become a driver of disease …See details»

Transforming the Treatment of Brain Health - Delix Therapeutics

Delix is changing the way we think about treating the brain. By leveraging the brain’s own ability to grow and form connections—a process known as neuroplasticity—we are discovering that by …See details»

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics is at the point of impact for CRS. Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic …See details»

linkstock.net © 2022. All rights reserved